The vaccine is the only protein-based COVID shot still in use in the U.S. This approval would allow the vaccine to stay on ...

At FDA, full vaccine approval is the gold standard. The agency was on track to sign off on Novavax’s license by its April 1 ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that the German Standing ... All the news that moves the needle in pharma and biotech Exclusive features, podcasts, interviews, data analyses ...

U.S. biotechnology company Colossal Biosciences claims it has produced three dire wolves, a species that has been extinct for over 10,000 years. The wolf cubs were “successfully birthed” by ...

and a wonderful example of the power of biotechnology to protect species, both extant and extinct.” Drew Weisholtz is a reporter for TODAY Digital, focusing on pop culture, nostalgia and ...

Sifting through countless of stocks in the Biotechnology industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

For instance, the global use of mRNA-based vaccines (e.g., Pfizer, Moderna) is currently constrained by ultracold storage requirements. This highlights the need for strategies to enhance stability ...

If this happens, it could be transformational for the biotech player. Now I'm going to turn to the recent news that's weighed on Moderna, and that's Marks' departure from the FDA. Marks ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $39.00. The company’s shares closed yesterday ...